Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,44 € ↑0,88 (1,88%)
2026-06-03
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionFoster & Motley Inc
Latest Disclosed Ownership47,739 shares
Latest Disclosed Value $ 2,895
Foster & Motley Inc reports 20.42% increase in ownership of BRM / Bristol-Myers Squibb Company

On April 21, 2026 - Foster & Motley Inc filed a 13F-HR form disclosing ownership of 47,739 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $2,502,478 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 15, 2026 disclosing 39,643 shares of Bristol-Myers Squibb Company. This represents a change in shares of 20.42% during the quarter. The current value of the position is $2,264,499 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-21 2026-03-31 13F Bristol-Myers Squibb com 110122108 47,739 8,096 20.42 3 0.00 0.1494
2026-01-15 2025-12-31 13F Bristol-Myers Squibb com 110122108 39,643 -12,772 -24.37 2 0.00 0.1140
2025-10-23 2025-09-30 13F Bristol-Myers Squibb com 110122108 52,415 922 1.79 2 0.00 0.1274
2025-07-29 2025-06-30 13F Bristol-Myers Squibb com 110122108 51,493 13,268 34.71 2 0.00 0.1377
2025-05-08 2025-03-31 13F Bristol-Myers Squibb com 110122108 38,225 5,383 16.39 2 100.00 0.1468
2025-01-23 2024-12-31 13F Bristol-Myers Squibb com 110122108 32,842 6,684 25.55 2 0.00 0.1208
2024-10-30 2024-09-30 13F Bristol-Myers Squibb com 110122108 26,158 -3,350 -11.35 1 0.00 0.0858
2024-08-02 2024-06-30 13F Bristol-Myers Squibb com 110122108 29,508 -831 -2.74 1 0.00 0.0842
2024-04-18 2024-03-31 13F Bristol-Myers Squibb com 110122108 30,339 -3,773 -11.06 2 0.00 0.1132
2024-02-01 2023-12-31 13F Bristol-Myers Squibb com 110122108 34,112 -9,981 -22.64 2 -50.00 0.1300
2023-10-24 2023-09-30 13F Bristol-Myers Squibb com 110122108 44,093 -4,360 -9.00 3 -33.33 0.2098
2023-08-08 2023-06-30 13F Bristol-Myers Squibb com 110122108 48,453 4,026 9.06 3 0.00 0.2400
2023-05-09 2023-03-31 13F Bristol-Myers Squibb com 110122108 44,427 13,241 42.46 3 50.00 0.2506
2023-02-09 2022-12-31 13F Bristol-Myers Squibb com 110122108 31,186 3,299 11.83 2 -99.90 0.1915
2022-11-04 2022-09-30 13F Bristol-Myers Squibb com 110122108 27,887 3,586 14.76 1,983 5.99 0.1883
2022-08-09 2022-06-30 13F Bristol-Myers Squibb com 110122108 24,301 6,527 36.72 1,871 44.14 0.1644
2022-04-28 2022-03-31 13F Bristol-Myers Squibb com 110122108 17,774 464 2.68 1,298 20.30 0.1018
2022-01-25 2021-12-31 13F Bristol-Myers Squibb com 110122108 17,310 -6,381 -26.93 1,079 -23.04 0.0840
2021-10-29 2021-09-30 13F Bristol-Myers Squibb com 110122108 23,691 3,107 15.09 1,402 1.96 0.1167
2021-07-20 2021-06-30 13F Bristol-Myers Squibb com 110122108 20,584 7,414 56.29 1,375 65.46 0.1151
2021-04-26 2021-03-31 13F Bristol-Myers Squibb com 110122108 13,170 3,835 41.08 831 43.52 0.0693
2021-02-01 2020-12-31 13F Bristol-Myers Squibb com 110122108 9,335 220 2.41 579 5.27 0.0559
2020-10-19 2020-09-30 13F Bristol-Myers Squibb com 110122108 9,115 -388 -4.08 550 -1.61 0.0648
2020-07-20 2020-06-30 13F Bristol-Myers Squibb com 110122108 9,503 -1,789 -15.84 559 -11.13 0.0699
2020-04-21 2020-03-31 13F Bristol-Myers Squibb com 110122108 11,292 3,310 41.47 629 22.85 0.0938
2020-02-05 2019-12-31 13F Bristol-Myers Squibb com 110122108 7,982 3,177 66.12 512 109.84 0.0641
2019-10-24 2019-09-30 13F Bristol-Myers Squibb com 110122108 4,805 4,805 244 0.0332
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.